Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure

被引:13
作者
Bernocchi, P
Cargnoni, A
Vescovo, G
Dalla Libera, L
Parrinello, G
Boraso, A
Ceconi, C
Ferrari, R
机构
[1] Fdn Salvatore Maugeri, Cardiovasc Res Ctr, IRCCS, I-25064 Gussago, Brescia, Italy
[2] Hosp Adria, Dept Internal Med, Rovigo, Italy
[3] Univ Padua, CNR, Unit Muscle Physiopathol, I-35100 Padua, Italy
[4] Univ Brescia, Dept Stat, I-25121 Brescia, Italy
[5] Univ Brescia, Chair Cardiol, I-25121 Brescia, Italy
[6] Hosp Brescia, Chair Cardiol, Brescia, Italy
[7] Univ Ferrara, Chair Cardiol, I-44100 Ferrara, Italy
关键词
heart failure; oxidative capacity; skinned muscle fibres; O-2; consumption;
D O I
10.1007/s003950300001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In congestive heart failure (CHF), function and metabolism of skeletal muscles are abnormal. Aim To evaluate whether the reduced oxidative capacity of skeletal muscles in CHF is due to impaired 0, utilisation. Methods CHF was induced in rats by injecting 50 mg/Kg monocrotaline. Several animals received the same dose of monocrotaline but only compensated right ventricular hypertrophy and no sign of congestion resulted. Two age- and diet-matched groups of control animals were also studied. in soleus and extensor digitorum longus (EDL) muscles, we studied skeletal muscle blood flow, oxidative capacity and respiratory function of skinned muscle fibres. Results In CHF, we observed a decrease of muscle blood flow (statistically significant in the soleus, p < 0.05 vs. controls). In compensated rats, a similar trend in blood flow was observed. in both soleus and EDL, a significant reduction of high energy phosphate and a shift of the redox potential towards accumulation of reducing equivalents were observed. The reduction of energy charge was not correlated to the decrease of blood flow. In skinned myofibres, the ratio of 0, utilised in the presence and in absence of ADP (an index of phoshorilating efficiency) was reduced from 8.9 +/- 1.9 to 2.7 +/- 0.2 (p < 0.001) and from 5.7 +/- 1.0 to 2.0 +/- 0.3 (p < 0.01) in soleus and EDL, respectively. Activity of the different complexes of respiratory chain was investigated by means of specific inhibitors, showing major abnormalities at the level of complex I. In fact, inhibition of VO2 by rotenone was decreased from 83.5 +/- 3.2 to 36.4 +/- 9.6 % (p < 0.005) and from 81.8 +/- 6.1 to 38.2 +/- 7.4 % (p < 0.005) in soleus and EDL, respectively. Conclusions In rats with CHF, abnormalities of oxidative phosphorylation of muscles occur and complex I of the respiratory chain seem to be primarily affected. The metabolic alterations of skeletal muscles in CHF may be explained, at least in part, by an impaired O-2 utilisation.
引用
收藏
页码:114 / 123
页数:10
相关论文
共 44 条
[1]   PHYSICAL-TRAINING IMPROVES SKELETAL-MUSCLE METABOLISM IN PATIENTS WITH CHRONIC HEART-FAILURE [J].
ADAMOPOULOS, S ;
COATS, AJS ;
BRUNOTTE, F ;
ARNOLDA, L ;
MEYER, T ;
THOMPSON, CH ;
DUNN, JF ;
STRATTON, J ;
KEMP, GJ ;
RADDA, GK ;
RAJAGOPALAN, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (05) :1101-1106
[2]   EDEMA OF CARDIAC ORIGIN - STUDIES OF BODY-WATER AND SODIUM, RENAL-FUNCTION, HEMODYNAMIC INDEXES, AND PLASMA HORMONES IN UNTREATED CONGESTIVE CARDIAC-FAILURE [J].
ANAND, IS ;
FERRARI, R ;
KALRA, GS ;
WAHI, PL ;
POOLEWILSON, PA ;
HARRIS, PC .
CIRCULATION, 1989, 80 (02) :299-305
[3]  
Anker SD, 1997, CIRCULATION, V96, P526
[4]   ENERGY CHARGE OF ADENYLATE POOL AS A REGULATORY PARAMETER . INTERACTION WITH FEEDBACK MODIFIERS [J].
ATKINSON, DE .
BIOCHEMISTRY, 1968, 7 (11) :4030-&
[5]   Skeletal muscle metabolism in experimental heart failure [J].
Bernocchi, P ;
Ceconi, C ;
Pedersini, P ;
Pasini, E ;
Curello, S ;
Ferrari, R .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (11) :2263-2273
[6]   EXTRACTION AND ASSAY OF CREATINE-PHOSPHATE, PURINE, AND PYRIDINE-NUCLEOTIDES IN CARDIAC TISSUE BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BERNOCCHI, P ;
CECONI, C ;
CARGNONI, A ;
PEDERSINI, P ;
CURELLO, S ;
FERRARI, R .
ANALYTICAL BIOCHEMISTRY, 1994, 222 (02) :374-379
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   MUSCLE ENERGY-METABOLISM IN SEVERE CHRONIC CONGESTIVE-HEART-FAILURE - EFFECT OF TREATMENT WITH ENALAPRIL [J].
BROQVIST, M ;
DAHLSTROM, U ;
KARLSSON, E ;
LARSSON, J .
EUROPEAN HEART JOURNAL, 1992, 13 (09) :1217-1224
[9]   NORADRENALINE, ATRIAL NATRIURETIC PEPTIDE, BOMBESIN AND NEUROTENSIN IN MYOCARDIUM AND BLOOD OF RATS IN CONGESTIVE CARDIAC-FAILURE [J].
CECONI, C ;
CONDORELLI, E ;
QUINZANINI, M ;
RODELLA, A ;
FERRARI, R ;
HARRIS, P .
CARDIOVASCULAR RESEARCH, 1989, 23 (08) :674-682
[10]   Insulin resistance in chronic heart failure [J].
Coats, AJS ;
Anker, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 :S9-S14